M. Lebwohl, L. Green, M. Bettencourt, S. Fretzin, and A. Jacobson, “Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics”, J of Skin, vol. 3, p. S22, Nov. 2019.